Infectious Disease
1892, Argentina — Clinical and pathological documentation by Alejandro Posadas and Robert Wernicke
Coccidioidomycosis, a fungal disease caused by inhaling spores of Coccidioides organisms native to arid regions of the Americas, was first recognized as a distinct medical entity in the late nineteenth century when it was initially and mistakenly believed to be caused by a protozoan parasite. Early physicians who encountered severe cases assumed they were dealing with an invariably fatal condition, unaware that most infections resolved without causing severe illness. The disease's true fungal nature and the spectrum of its clinical outcomes were only clarified through decades of painstaking laboratory and epidemiological investigation.
Historical Narrative
The first scientifically documented encounter with coccidioidomycosis occurred in 1892 in Argentina, when a military soldier named Domingo Escurra presented with a severe and ultimately fatal disseminated illness. The attending physician, Alejandro Posadas, along with pathologist Robert Wernicke, examined tissue samples from the lesions and observed unusual organisms they believed to be protozoa of the genus Coccidium, drawing comparisons to known parasitic infections. Posadas carefully documented and illustrated his findings, and his meticulous records preserved what became recognized as the foundational case in the condition's medical history. The organism was accordingly given the name Coccidioides, reflecting this early and mistaken belief in its protozoan nature.
Almost simultaneously, in 1894, a separate and independent case was identified in California by physician Emmett Rixford, who along with T.C. Gilchrist published their observations of a Portuguese laborer with a similarly severe disseminated illness. Rixford and Gilchrist also interpreted the causative organism as a protozoan, reinforcing the prevailing misclassification. For several years, the medical literature treated this condition as an exceedingly rare and almost universally lethal protozoan infection, an assumption shaped entirely by the fact that only the most dramatic and fatal cases were coming to physicians' attention.
The understanding of coccidioidomycosis underwent a fundamental transformation in the first decade of the twentieth century. In 1900, William Ophüls and Herbert Moffitt, working in San Francisco, successfully cultured the organism and demonstrated conclusively that it was not a protozoan but rather a fungus, establishing the correct classification that subsequent researchers would build upon. This correction was enormously significant, repositioning coccidioidomycosis within the emerging field of medical mycology and prompting comparisons with other fungal pathogens that were being identified during the same era.
For the next several decades, the disease was still thought to be rare and almost always fatal. This perception persisted until the 1930s, when researcher Charles Edward Smith and his colleagues at Stanford and later the University of California conducted extensive epidemiological investigations in California's San Joaquin Valley, a region where the disease was endemic. Smith's team developed a skin test using coccidioidin, a preparation derived from the fungus, and discovered through large-scale surveys that an enormous proportion of individuals living in endemic regions showed evidence of prior infection, indicating they had recovered without ever developing severe illness. This revelation overturned the assumption of near-universal lethality and established that most infections had been self-limited and unrecognized.
During World War II, military training camps located in the southwestern United States brought large numbers of nonimmune recruits into endemic zones, and a notable surge in cases among military personnel focused intense federal research attention on the disease. The wartime epidemics accelerated funding and scientific interest, leading to more refined understanding of which populations faced greater risk of severe outcomes. Smith's continued work through the 1940s and 1950s remained foundational in shaping the epidemiological picture of what had once been considered an obscure and exotic rarity.
By mid-century, coccidioidomycosis had been transformed in medical understanding from a presumed protozoan curiosity into a well-characterized fungal disease with a defined geographic distribution, a recognized spectrum of outcomes, and a compelling history of scientific misidentification that illustrated the challenges of early-twentieth-century infectious disease research.
Key Historical Figures
Historical narrative only — this page describes how Coccidioidomycosis was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.